Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Kirman

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Regulatory Toxicology and Pharmacology : RTP|June 11, 2018
Biomonitoring Equivalents for cyanideC R Kirman, A M Belknap, A F Webster, et al.
Chemico-Biological Interactions|August 27, 2022
An updated lymphohematopoietic and bladder cancers risk evaluation for occupational and environmental exposures to 1,3-butadieneC Valdez-Flores, N Erraguntla, R Budinsky, et al.
Journal of Toxicology and Environmental Health. Part A|October 4, 2012
Screening-level risk assessment for styrene-acrylonitrile (SAN) trimer detected in soil and groundwaterC R Kirman, M L Gargas, J J Collins, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 5, 2000
Improving cancer dose-response characterization by using physiologically based pharmacokinetic modeling: an analysis of pooled data for acrylonitrile-induced brain tumors to assess cancer potency in the ratC R Kirman, S M Hays, G L Kedderis, et al.
Regulatory Toxicology and Pharmacology : RTP|April 9, 2025
Human health risk assessment for exposures to 1,3-butadiene in the United States with input from an independent science advisory panelC R Kirman, G Boysen, M J DiNovi, et al.
Regulatory Toxicology and Pharmacology : RTP|August 4, 2022
Use of biomarker data and metabolite relative potencies to support derivation of noncancer reference values based on the reproductive and developmental toxicity effects of 1,3-butadieneC R Kirman, C M North, N Y Tretyakova, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 3, 2008
Derivation of noncancer reference values for acrylonitrileC R Kirman, L M Sweeney, M L Gargas, et al.
Regulatory Toxicology and Pharmacology : RTP|September 27, 2025
Expert panel evaluation of the tumor modes of action for 1,4-dioxane and their implications for human risk assessmentC R Kirman, J S Bus, S Gupta, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|December 16, 2020
Ethylene oxide review: characterization of total exposure via endogenous and exogenous pathways and their implications to risk assessment and risk managementC R Kirman, A A Li, P J Sheehan, et al.
Regulatory Toxicology and Pharmacology : RTP|January 19, 2016
Using physiologically based pharmacokinetic modeling and benchmark dose methods to derive an occupational exposure limit for N-methylpyrrolidoneT S Poet, P M Schlosser, C E Rodriguez, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Regulatory Toxicology and Pharmacology : RTP|June 11, 2018
Biomonitoring Equivalents for cyanideC R Kirman, A M Belknap, A F Webster, et al.
Chemico-Biological Interactions|August 27, 2022
An updated lymphohematopoietic and bladder cancers risk evaluation for occupational and environmental exposures to 1,3-butadieneC Valdez-Flores, N Erraguntla, R Budinsky, et al.
Journal of Toxicology and Environmental Health. Part A|October 4, 2012
Screening-level risk assessment for styrene-acrylonitrile (SAN) trimer detected in soil and groundwaterC R Kirman, M L Gargas, J J Collins, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 5, 2000
Improving cancer dose-response characterization by using physiologically based pharmacokinetic modeling: an analysis of pooled data for acrylonitrile-induced brain tumors to assess cancer potency in the ratC R Kirman, S M Hays, G L Kedderis, et al.
Regulatory Toxicology and Pharmacology : RTP|April 9, 2025
Human health risk assessment for exposures to 1,3-butadiene in the United States with input from an independent science advisory panelC R Kirman, G Boysen, M J DiNovi, et al.
Regulatory Toxicology and Pharmacology : RTP|August 4, 2022
Use of biomarker data and metabolite relative potencies to support derivation of noncancer reference values based on the reproductive and developmental toxicity effects of 1,3-butadieneC R Kirman, C M North, N Y Tretyakova, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 3, 2008
Derivation of noncancer reference values for acrylonitrileC R Kirman, L M Sweeney, M L Gargas, et al.
Regulatory Toxicology and Pharmacology : RTP|September 27, 2025
Expert panel evaluation of the tumor modes of action for 1,4-dioxane and their implications for human risk assessmentC R Kirman, J S Bus, S Gupta, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|December 16, 2020
Ethylene oxide review: characterization of total exposure via endogenous and exogenous pathways and their implications to risk assessment and risk managementC R Kirman, A A Li, P J Sheehan, et al.
Regulatory Toxicology and Pharmacology : RTP|January 19, 2016
Using physiologically based pharmacokinetic modeling and benchmark dose methods to derive an occupational exposure limit for N-methylpyrrolidoneT S Poet, P M Schlosser, C E Rodriguez, et al.
Pageof 4